| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800089 | 重组抗VEGFR2结构域II-III全人单克隆抗体注射液 | Injection | Biological Products(2) | New Drug Application | 2018-08-14 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2018-10-22 | view |